Alzheon announced the launch of the company, the securing of initial private financing, and the signing of an exclusive license agreement to a novel clinical drug candidate for Alzheimer’s disease, a family of analogs, and a drug ...
Tags: Alzheon, Alzheimer's Disease
Senesco Technologies reported the treatment of the first patient at the Company’s newly opened clinical-trial site at Seattle Cancer Care Alliance (SCCA). This patient is part of Senesco’s Phase 1b/2a clinical study of its ...
Tags: Senesco, Clinical Trial
Cervel Neurotech has initiated a clinical study for patients suffering from treatment resistant depression at seven leading academic and research centers in the US. The 80-patient trial, designed as a randomized, sham-controlled, double ...
US-based Medtronic has announced the first implantations of its CoreValve Evolut R recapturable system as part of a clinical study. CoreValve Evolut R recapturable system has CoreValve Evolut R transcatheter valve and EnVeo R recapturable ...
Biomet, a manufacturer of orthopedic and biotechnology products, has announced the first US implantation of its Comprehensive nano stemless shoulder as part of an US Food and Drug Administration investigational device exemption (IDE) ...
Tags: Biomet, Nano Stemless Shoulder
Israel-based Cardiosonic announced it is currently enrolling patients in the TIVUS II clinical trial, designed to assess the safety, efficacy and performance of its TIVUS system using a next generation multidirectional catheter. TIVUS ...
Tags: Cardiosonic, Clinical Trial
PLC Systems, a medical device company, has obtained an approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to initiate a single-arm clinical trial in Japan using its RenalGuard therapy. This approval is based on MHLW's ...
Tags: PLC Systems, Renalguard Therapy
US-based Pulsar Vascular has obtained CE Mark approval for its PulseRider device, designed to bridge the neck of cerebral aneurysms previously not amenable to endovascular therapy. With this CE Mark approval, the company now has full ...
Tags: Pulsar Vascular, CE Mark Approval
Biotronik, a manufacturer of cardio and endovascular medical devices, has announced that its DREAMS scaffold (DRug Eluting Absorbable Metal Scaffold) has been successfully implanted in the first coronary artery disease patient in Germany as ...
Tags: Biotronik, medical devices
US-based medical device company Moximed has announced the successful completion of 500th worldwide implant of its KineSpring system, intended to provide a new treatment option for patients with mild-to-moderate knee osteoarthritis. The ...
Tags: Kinespring System, medical device
Allegro Ophthalmics has received approval from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to commence two Phase II clinical studies of integrin peptide therapy ALG-1001. The new trials, ...
Tags: Eye Disease Patients
The US Food and Drug Administration (FDA) advisory panel has recommended the expanded indication of Medtronic’s cardiac resynchronization therapy-pacemakers and -defibrillators (CRT-P and CRT-D) for the treatment of patients who ...
The Israeli Ministry of Health (IMH) has approved Pluristem Therapeutics’ request to start a Phase II trial using its PLacental eXpanded (PLX) cells in the treatment of intermittent claudication (IC). IC is a subset of peripheral ...
Tags: clinical study, Medicine
TVA Medical, a medical device company focused on endovascular innovation, has announced that its vascular catheter-based Flex system for hemodialysis access has demonstrated success in the FLEX-1 pilot study. Recently, the company ...
Tags: TVA Medical, Medicine
Biopharmaceutical company Trigemina will deliver clinical data on its drug candidate TI-001 for the treatment of chronic migraine at the ongoing 7th Annual Pain Therapeutics Summit East in Boston, Massachusetts. The presentation will ...
Tags: Migraine Drug, Medicine